Skip to main content

The Globe and Mail

The Globe's stars and dogs for the week: Dick's Sporting Goods shares land in the rough

A humorous look at the companies that caught our eye, for better or worse, this week.

DOG: Dick's Sporting Goods

How to lose money at golf: 

1) After your second quadruple-bogey, wrap your new $1,000 driver around a tree
2) Make a wager with a guy who turns out to be a former touring pro
3) Invest in Dick’s Sporting Goods

Citing a “continued significant decline” in its golf business, which has been hurt by a glut of inventory and a decline in the sport’s popularity, the retailer chopped its full-year sales and profit outlook, sending the shares into the sand trap.

DKS (NYSE), $43.08 (U.S.)

down $8.49 or 16.5% over week 

STAR: Royal Bank of Canada

The press release that got rejected:

Royal Bank of Canada is pleased to report that, in the fiscal second-quarter ended April 30, 2014, net income rose 15 per cent to $2.2-billion. In light of these solid results – driven by strength in wealth management, lending and capital markets – we will be reducing service charges, slashing lending rates and offering free hot dogs and soft drinks throughout the summer at all of our branches.


RY (TSX), $75.30

up $2.46 or 3.4% over week

STAR: Tiffany & Co.

“Here honey. I got you something from Tiffany.”

“Really!? A diamond necklace!?”

“Nope.”

“A pair of gold earrings!?”

“Nope. It’s 100 shares of Tiffany & Co..The company’s first-quarter earnings soared and I figure the shares will hold their value better than any stupid overpriced bauble.”

“How romantic of you.”


TIF (NYSE), $96.59 (U.S.)

up $6.11 or 6.7% over week 

STAR: Ophthotech

Ophthotech – try saying that three times fast. However you pronounce it, the word was music to the ears – or you might say the eyes – of investors this week. The biotech company said it could potentially receive more than $1-billion under a deal with Novartis to market Ophthotech’s experimental eye drug Fovista – which treats macular degeneration – outside the United States. Investors can see the money clearly now.


OPHT (Nasdaq), $38.03 (U.S.)

up $6.95 or 22.4% over week

DOG: PetSmart Inc.

Oh no. Here she comes again with that ridiculous doggy sweater. I hate wearing that thing. I’ve got fur if you haven’t noticed! And those ridiculous booties are always falling off. Why don’t you just let me be a dog for Pete’s sake? Ya know, a lot of owners are skipping all the stupid doggy accessories, judging by PetSmart’s sluggish sales. Guess you didn’t get the memo.


PETM (Nasdaq), $55.30 (U.S.)

down $9.67 or 14.9% over week

Story continues below advertisement

Report an error Editorial code of conduct Licensing Options
As of December 20, 2017, we have temporarily removed commenting from our articles. We hope to have this resolved by the end of January 2018. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.